DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Methazolamide (Methazolamide) - Summary

 
 



METHAZOLAMIDE SUMMARY

METHAZOLAMIDE TABLETS USP
25 mg and 50 mg

Methazolamide, a sulfonamide derivative, is a white crystalline powder, weakly acidic, slightly soluble in water, alcohol and acetone.

Methazolamide tablets are indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.


See all Methazolamide indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Methazolamide

Glaucoma Drug Eyed as Novel Diabetes Treatment 'Archetype'
Source: Medscape Diabetes & Endocrinology Headlines [2014.08.21]
An old glaucoma drug, methazolamide, improved glucose control in a small study, probably due to a distinct mechanism that the manufacturer, Verva, hopes to pursue.
Medscape Medical News

more news >>

Clinical Trials Related to Methazolamide

Rapid Acclimatization to Hypoxia at Altitude [Recruiting]
In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e. g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline.

Improving Tumor Oxygenation in Cervical Cancer [Withdrawn]
The Phenomenon of Tumor Hypoxia Many solid tumors are relatively resistant to treatment with ionizing radiation and certain chemotherapeutic agents such as anthracyclines that are affected adversely by acidic pH. These effects have primarily been attributed to the presence of hypoxic cells within the tumor. The relevance of hypoxia with respect to failure of radiotherapy to cure certain malignancies has had a chequered history. However, in recent years the evidence that hypoxia plays a central role in relative radioresistance has become more compelling.

Since approximately two-thirds of all women suffering from cervical carcinoma receive radiation as a component of their therapy, an enhanced understanding of the interactions between hypoxia and radiation as a component of their therapy, an enhanced understanding of the interactions between hypoxia and radiation resistance is critical to improving outcome among those with cervical cancer.

more trials >>


Page last updated: 2014-08-21

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014